The table below shows OCULAR THERAPEUTIX, INC's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$65.99M
-$44.67M
-$33.89M
-$19.97M
-$18.60M
-$17.36M
Capital expenditure
$4.66M
$1.93M
$255.00K
$3.38M
$276.00K
$158.00K
Investing cash flow
-$4.66M
-$1.93M
-$255.00K
-$3.38M
-$276.00K
-$158.00K
Dividends paid
-
-
-
OCUL operating cash flow (10-K history)
OCULAR THERAPEUTIX, INC reported operating cash flow of -$204.88M for fiscal year 2025. That is down 52.1% from -$134.68M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$34.00M (FY 2016) to -$204.88M. Figures come from the company's audited annual reports as filed with the SEC.